查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1859891

冠狀動脈繞道手術手術（CABG）：全球市場佔有率和排名、總銷售額和需求預測（2025-2031 年）

Coronary Artery Bypass Grafts (CABG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 95 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球冠狀動脈繞道手術手術 (CABG) 市場規模預計在 2024 年達到 1.42 億美元，預計到 2031 年將達到 2.02 億美元，在預測期（2025-2031 年）以 5.2% 的複合年成長率成長。

冠狀動脈繞道術（CABG 手術），俗稱心臟繞道手術或搭橋手術，是一種恢復阻塞的冠狀動脈正常血流的外科手術。

冠狀動脈繞道手術手術（CABG）是一種外科手術，它利用自體或人工血管在狹窄或阻塞的冠狀動脈周圍建立旁路通路，從而恢復心肌的血液供應。這可以保護心肌，緩解缺血症狀，並降低不良心臟事件的風險。作為多支血管和複雜冠狀動脈疾病的標準治療方法，CABG涵蓋了從傳統的開胸體外循環到先進的微創技術以及輔助支持方法。手術全期生態系（包括移植血管的保存、術中灌注管理、止血、耗材和術後復健）構成了一個完整的市場，涵蓋醫療設備、一次性耗材、藥物輔助治療和服務。

公共衛生領域對心血管疾病負擔的持續關注，為冠狀動脈繞道手術（CABG）領域提供了永續的需求基礎，因為持久的療效和長期的生活品質至關重要。移植物保存、術中血液管理和替代移植物材料方面的創新，以及上市公司和研發公司不斷擴大的商業化規模，正在拓展可供選擇的產品類型類別，並為那些能夠將臨床證據與可擴展的生產能力相結合的公司創造了絕佳的商業機會。

關鍵阻礙因素包括嚴格的監管要求、對長期臨床證據的需求以及嚴格的品管。新型器械和移植材料通常需要漫長的臨床試驗以及與監管機構的溝通，才能納入標準手術流程。上市後的安全或品質問題可能會對合規成本和品牌信譽產生重大影響。供應鏈的穩健性、無菌生產能力以及醫院預算動態也構成特定的商業化風險。

本報告旨在依地區/國家、類型和應用對全球冠狀動脈繞道手術移植術 (CABG) 市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本文以收益為準，以 2024 年為基準年，對冠狀動脈繞道手術移植術 (CABG) 的市場規模、估算和預測進行了闡述，並包含了 2020 年至 2031 年的歷史數據和預測數據。透過定量和定性分析，我們幫助讀者制定業務/成長策略，評估市場競爭格局，分析自身在當前市場中的地位，並就冠狀動脈繞道手術術 (CABG) 做出明智的商業決策。

市場區隔

公司

  • Medtronic
  • Getinge Group
  • LivaNova
  • Terumo
  • Boston Scientific
  • Stryker
  • Edwards Lifesciences
  • Genesee Biomedical
  • Karl Storz GmbH

依類型分類的區隔市場

  • 大隱靜脈移植
  • 內乳動脈移植
  • 其他

應用領域

  • 傳統冠狀動脈繞道手術
  • 非傳統冠狀動脈繞道手術

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Coronary Artery Bypass Grafts (CABG) was estimated to be worth US$ 142 million in 2024 and is forecast to a readjusted size of US$ 202 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

Coronary artery bypass grafting (CABG) is a surgical intervention to restore myocardial blood supply by creating bypass conduits-using autologous or alternative vascular grafts-around narrowed or occluded coronary arteries to preserve cardiac muscle, relieve ischemic symptoms, and reduce the risk of adverse cardiac events. As a standard of care for multivessel and complex coronary disease, CABG spans from conventional open-chest on-pump procedures to refined, less invasive techniques and supporting adjuncts. The perioperative ecosystem-graft preservation, intraoperative perfusion management, hemostasis, consumables, and postoperative rehabilitation-forms an integrated market that includes devices, disposables, pharmacologic adjuncts, and service offerings.

The sustained public-health emphasis on cardiovascular disease burden provides an enduring demand base for CABG where durable outcomes and long-term quality of life matter. Innovations in graft preservation, intraoperative blood management and alternative conduit materials, together with commercialization by listed and R&D companies, are expanding addressable product categories and creating premium commercialization opportunities for firms that can pair clinical evidence with scalable manufacturing.

Major restraints include rigid regulatory requirements, the need for long-term clinical evidence, and stringent quality controls. Novel devices and graft materials typically require extended clinical programs and regulatory interactions before adoption into standard surgical pathways; post-market safety or quality issues can materially impact compliance costs and brand trust. Supply-chain robustness, sterile manufacturing capability, and hospital budget dynamics also present tangible commercialization risks.

This report aims to provide a comprehensive presentation of the global market for Coronary Artery Bypass Grafts (CABG), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Coronary Artery Bypass Grafts (CABG) by region & country, by Type, and by Application.

The Coronary Artery Bypass Grafts (CABG) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Artery Bypass Grafts (CABG).

Market Segmentation

By Company

  • Medtronic
  • Getinge Group
  • LivaNova
  • Terumo
  • Boston Scientific
  • Stryker
  • Edwards Lifesciences
  • Genesee Biomedical
  • Karl Storz GmbH

Segment by Type

  • Saphenous Vein Grafts
  • Internal Thoracic Artery Grafts
  • Other

Segment by Application

  • Traditional CABG
  • Nontraditional CABG

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Coronary Artery Bypass Grafts (CABG) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Coronary Artery Bypass Grafts (CABG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Coronary Artery Bypass Grafts (CABG) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Coronary Artery Bypass Grafts (CABG) Product Introduction
  • 1.2 Global Coronary Artery Bypass Grafts (CABG) Market Size Forecast (2020-2031)
  • 1.3 Coronary Artery Bypass Grafts (CABG) Market Trends & Drivers
    • 1.3.1 Coronary Artery Bypass Grafts (CABG) Industry Trends
    • 1.3.2 Coronary Artery Bypass Grafts (CABG) Market Drivers & Opportunity
    • 1.3.3 Coronary Artery Bypass Grafts (CABG) Market Challenges
    • 1.3.4 Coronary Artery Bypass Grafts (CABG) Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Coronary Artery Bypass Grafts (CABG) Players Revenue Ranking (2024)
  • 2.2 Global Coronary Artery Bypass Grafts (CABG) Revenue by Company (2020-2025)
  • 2.3 Key Companies Coronary Artery Bypass Grafts (CABG) Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Coronary Artery Bypass Grafts (CABG) Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Coronary Artery Bypass Grafts (CABG)
  • 2.6 Coronary Artery Bypass Grafts (CABG) Market Competitive Analysis
    • 2.6.1 Coronary Artery Bypass Grafts (CABG) Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Coronary Artery Bypass Grafts (CABG) Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Artery Bypass Grafts (CABG) as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Saphenous Vein Grafts
    • 3.1.2 Internal Thoracic Artery Grafts
    • 3.1.3 Other
  • 3.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type
    • 3.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value, by Type (2020-2031)
    • 3.2.3 Global Coronary Artery Bypass Grafts (CABG) Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Traditional CABG
    • 4.1.2 Nontraditional CABG
  • 4.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application
    • 4.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value, by Application (2020-2031)
    • 4.2.3 Global Coronary Artery Bypass Grafts (CABG) Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region
    • 5.1.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2020-2025)
    • 5.1.3 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2026-2031)
    • 5.1.4 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.2.2 North America Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.3.2 Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Coronary Artery Bypass Grafts (CABG) Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.5.2 South America Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.3.2 United States Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.4.2 Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.5.2 China Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.6.2 Japan Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.7.2 South Korea Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.9.2 India Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Medtronic
    • 7.1.1 Medtronic Profile
    • 7.1.2 Medtronic Main Business
    • 7.1.3 Medtronic Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.1.4 Medtronic Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Medtronic Recent Developments
  • 7.2 Getinge Group
    • 7.2.1 Getinge Group Profile
    • 7.2.2 Getinge Group Main Business
    • 7.2.3 Getinge Group Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.2.4 Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Getinge Group Recent Developments
  • 7.3 LivaNova
    • 7.3.1 LivaNova Profile
    • 7.3.2 LivaNova Main Business
    • 7.3.3 LivaNova Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.3.4 LivaNova Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.3.5 LivaNova Recent Developments
  • 7.4 Terumo
    • 7.4.1 Terumo Profile
    • 7.4.2 Terumo Main Business
    • 7.4.3 Terumo Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.4.4 Terumo Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Terumo Recent Developments
  • 7.5 Boston Scientific
    • 7.5.1 Boston Scientific Profile
    • 7.5.2 Boston Scientific Main Business
    • 7.5.3 Boston Scientific Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.5.4 Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Boston Scientific Recent Developments
  • 7.6 Stryker
    • 7.6.1 Stryker Profile
    • 7.6.2 Stryker Main Business
    • 7.6.3 Stryker Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.6.4 Stryker Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Stryker Recent Developments
  • 7.7 Edwards Lifesciences
    • 7.7.1 Edwards Lifesciences Profile
    • 7.7.2 Edwards Lifesciences Main Business
    • 7.7.3 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.7.4 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Edwards Lifesciences Recent Developments
  • 7.8 Genesee Biomedical
    • 7.8.1 Genesee Biomedical Profile
    • 7.8.2 Genesee Biomedical Main Business
    • 7.8.3 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.8.4 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Genesee Biomedical Recent Developments
  • 7.9 Karl Storz GmbH
    • 7.9.1 Karl Storz GmbH Profile
    • 7.9.2 Karl Storz GmbH Main Business
    • 7.9.3 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.9.4 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Karl Storz GmbH Recent Developments

8 Industry Chain Analysis

  • 8.1 Coronary Artery Bypass Grafts (CABG) Industrial Chain
  • 8.2 Coronary Artery Bypass Grafts (CABG) Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Coronary Artery Bypass Grafts (CABG) Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Coronary Artery Bypass Grafts (CABG) Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Coronary Artery Bypass Grafts (CABG) Market Trends
  • Table 2. Coronary Artery Bypass Grafts (CABG) Market Drivers & Opportunity
  • Table 3. Coronary Artery Bypass Grafts (CABG) Market Challenges
  • Table 4. Coronary Artery Bypass Grafts (CABG) Market Restraints
  • Table 5. Global Coronary Artery Bypass Grafts (CABG) Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Coronary Artery Bypass Grafts (CABG) Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Coronary Artery Bypass Grafts (CABG) Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Coronary Artery Bypass Grafts (CABG)
  • Table 10. Global Coronary Artery Bypass Grafts (CABG) Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Artery Bypass Grafts (CABG) as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Coronary Artery Bypass Grafts (CABG) Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Coronary Artery Bypass Grafts (CABG) Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Coronary Artery Bypass Grafts (CABG) Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Coronary Artery Bypass Grafts (CABG) Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Medtronic Basic Information List
  • Table 32. Medtronic Description and Business Overview
  • Table 33. Medtronic Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Medtronic (2020-2025)
  • Table 35. Medtronic Recent Developments
  • Table 36. Getinge Group Basic Information List
  • Table 37. Getinge Group Description and Business Overview
  • Table 38. Getinge Group Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Getinge Group (2020-2025)
  • Table 40. Getinge Group Recent Developments
  • Table 41. LivaNova Basic Information List
  • Table 42. LivaNova Description and Business Overview
  • Table 43. LivaNova Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of LivaNova (2020-2025)
  • Table 45. LivaNova Recent Developments
  • Table 46. Terumo Basic Information List
  • Table 47. Terumo Description and Business Overview
  • Table 48. Terumo Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Terumo (2020-2025)
  • Table 50. Terumo Recent Developments
  • Table 51. Boston Scientific Basic Information List
  • Table 52. Boston Scientific Description and Business Overview
  • Table 53. Boston Scientific Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Boston Scientific (2020-2025)
  • Table 55. Boston Scientific Recent Developments
  • Table 56. Stryker Basic Information List
  • Table 57. Stryker Description and Business Overview
  • Table 58. Stryker Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Stryker (2020-2025)
  • Table 60. Stryker Recent Developments
  • Table 61. Edwards Lifesciences Basic Information List
  • Table 62. Edwards Lifesciences Description and Business Overview
  • Table 63. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Edwards Lifesciences (2020-2025)
  • Table 65. Edwards Lifesciences Recent Developments
  • Table 66. Genesee Biomedical Basic Information List
  • Table 67. Genesee Biomedical Description and Business Overview
  • Table 68. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Genesee Biomedical (2020-2025)
  • Table 70. Genesee Biomedical Recent Developments
  • Table 71. Karl Storz GmbH Basic Information List
  • Table 72. Karl Storz GmbH Description and Business Overview
  • Table 73. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Karl Storz GmbH (2020-2025)
  • Table 75. Karl Storz GmbH Recent Developments
  • Table 76. Key Raw Materials Lists
  • Table 77. Raw Materials Key Suppliers Lists
  • Table 78. Coronary Artery Bypass Grafts (CABG) Downstream Customers
  • Table 79. Coronary Artery Bypass Grafts (CABG) Distributors List
  • Table 80. Research Programs/Design for This Report
  • Table 81. Key Data Information from Secondary Sources
  • Table 82. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Coronary Artery Bypass Grafts (CABG) Product Picture
  • Figure 2. Global Coronary Artery Bypass Grafts (CABG) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Coronary Artery Bypass Grafts (CABG) Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Coronary Artery Bypass Grafts (CABG) Report Years Considered
  • Figure 5. Global Coronary Artery Bypass Grafts (CABG) Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Coronary Artery Bypass Grafts (CABG) Revenue in 2024
  • Figure 7. Coronary Artery Bypass Grafts (CABG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Saphenous Vein Grafts Picture
  • Figure 9. Internal Thoracic Artery Grafts Picture
  • Figure 10. Other Picture
  • Figure 11. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Coronary Artery Bypass Grafts (CABG) Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Traditional CABG
  • Figure 14. Product Picture of Nontraditional CABG
  • Figure 15. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Coronary Artery Bypass Grafts (CABG) Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Coronary Artery Bypass Grafts (CABG) Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Coronary Artery Bypass Grafts (CABG) Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value (%), (2020-2031)
  • Figure 28. United States Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Coronary Artery Bypass Grafts (CABG) Industrial Chain
  • Figure 50. Coronary Artery Bypass Grafts (CABG) Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed